CJC-1295 is for serious athletes who want sustained growth hormone elevation
Notably, the STEP (Semaglutide Treatment Effect in People with obesity) trials, which specifically examined body composition, demonstrated substantial weight loss compared with placebo (NCT03548935) [53], and reductions in fat mass and visceral adipose tissue were accompanied by decreases in lean mass, although the proportion of lean mass relative to total body mass increased (NCT04074161) [54]
Andrade LJ, de Oliveira O, de Oliveira LM, L
The GDH genes were deleted and the phenotypes of the knockout mutants were studied by growth characterisation, metabolomics, isotope labelling experiments, and by quantifying cofactors under various hyphae-inducing conditions
In August 2025, Teva launched the first generic of liraglutide (Saxenda) for weight loss in adults and adolescents